Trulieve Cannabis Corp.
TCNNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,186 | $1,129 | $1,240 | $938 |
| % Growth | 5.1% | -8.9% | 32.1% | – |
| Cost of Goods Sold | $471 | $541 | $558 | $372 |
| Gross Profit | $716 | $589 | $682 | $566 |
| % Margin | 60.3% | 52.1% | 55% | 60.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $253 | $146 | $170 | $101 |
| SG&A Expenses | $510 | $386 | $455 | $316 |
| Sales & Mktg Exp. | $258 | $240 | $285 | $215 |
| Other Operating Expenses | $108 | $424 | $119 | $48 |
| Operating Expenses | $618 | $810 | $574 | $364 |
| Operating Income | $98 | -$222 | $109 | $197 |
| % Margin | 8.2% | -19.6% | 8.8% | 21% |
| Other Income/Exp. Net | -$55 | -$63 | -$69 | -$28 |
| Pre-Tax Income | $43 | -$285 | -$43 | $164 |
| Tax Expense | $198 | $151 | $162 | $146 |
| Net Income | -$155 | -$527 | -$205 | $18 |
| % Margin | -13.1% | -46.7% | -16.5% | 1.9% |
| EPS | -0.82 | -2.84 | -1.1 | 0.13 |
| % Growth | 71.1% | -158.2% | -946.2% | – |
| EPS Diluted | -0.82 | -2.84 | -1.09 | 0.12 |
| Weighted Avg Shares Out | 190 | 189 | 187 | 143 |
| Weighted Avg Shares Out Dil | 190 | 189 | 188 | 147 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | $6 | $2 | $0 |
| Interest Expense | $62 | $82 | $73 | $29 |
| Depreciation & Amortization | $166 | $170 | $186 | $78 |
| EBITDA | $259 | -$33 | $240 | $284 |
| % Margin | 21.8% | -2.9% | 19.3% | 30.2% |